Antiplatelet agents in acute coronary syndromes. Safety, patient selection are key concerns.
Steckel
L
L
D000208:Acute Disease; D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009722:Nurse Practitioners; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D012307:Risk Factors; D017751:Safety Management / Q000379:methods*
D010975:Platelet Aggregation Inhibitors